Case Report

Aftermath of Apixaban: Atypical Anticoagulation Aftereffect

Table 2

Additional laboratory testing ordered.

Lab testValueReference range

Hepatitis C abNegativeNegative
Rheumatoid factor<3.5 IU/mL0–39 IU/mL
CCP antibodies IgG/IgA5 units0–19 units
Antinuclear antibodiesNegative<1 : 80
Cytoplasmic ANCA<1 : 20 titer<1 : 20
Perinuclear ANCA<1 : 20 titer<1 : 20
Myeloperoxidase Ab<9 U/mL0.0–9 U/mL
Proteinase-3 Ab<3.5 U/mL0.0–3.5 U/mL
Atypical pANCA<1 : 20 titer<1 : 20
Complement C3231.8 mg/dL90–180 mg/dL
Complement C444.9 mg/dL9–36 mg/dL
Cardiolipin IgM ab<9 U/mL0–12 U/mL
Cardiolipin IgG ab<9 U/mL0–14 U/mL
Cardiolipin IgA ab<9 U/mL0–11 U/mL
CryoglobulinNot detectedNone
Beta-2 glycoprotein I IgG ab<9 units0–20 units
Beta-2 glycoprotein I Ig M ab15 units0–25 units
Beta-2 glycoprotein I Ig A ab15 units0–32 units